Form D · Biotechnology

AbiliLife, Inc.

Pittsburgh, PA · CIK 0001651121

Offering snapshot reported Oct 21, 2016 · SEC filing

Reported sold
$120K
Offering amount: $140K
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 29, 2016
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$60K$120KSep 6, 2016: $20,000.00Sep 6, 2016Oct 21, 2016: $120,000.00Oct 21, 2016

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$20,000 → $120,000
  • Reported investors1 → 2

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 21, 2016Amendment$120,000$100,000vs Sep 6, 20162SEC filing
Sep 6, 2016Initial$20,000No comparison1SEC filing
Aug 18, 2015Initial$50,000No comparison1SEC filing

Offering details

Securities
Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-270095
Agreement for Future Equity; Convertible Debt

Source: Form D, filed Oct 21, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Noah Papas Director, Executive
Courtney Williamson Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
6024 Broad Street 2 R
Pittsburgh, PA, 15206